Form 8-K - Current report:
SEC Accession No. 0001437749-26-013891
Filing Date
2026-04-29
Accepted
2026-04-29 16:27:47
Documents
12
Period of Report
2026-04-27
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20260428_8k.htm   iXBRL 8-K 36604
  Complete submission text file 0001437749-26-013891.txt   168762

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260427.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260427_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260427_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260427_pre.xml EX-101.PRE 11584
15 EXTRACTED XBRL INSTANCE DOCUMENT nby20260428_8k_htm.xml XML 2858
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 26916633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)